Primary Care Clinics in Garrettsville, OH Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Chiropractic Center Of Garrettsville Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 10697 Freedom St, Garrettsville, OH 44231 Phone: 330-527-5606 Fax: 330-527-5608 |
Garrettsville Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8307 Windham St, Garrettsville, OH 44231 Phone: 330-527-2617 Fax: 330-527-5099 |
S.m.leu Md Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8307 Windham St, Garrettsville, OH 44231 Phone: 330-527-2617 Fax: 330-527-5099 |
Andrews Eyecare Center Clinic/Center Medicare: Medicare Enrolled Practice Location: 1 Memory Ln Ste 100, Garrettsville, OH 44231 Phone: 330-527-3937 Fax: 330-527-3939 |
Psychological Healing Centers Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 8322 State Route 305, Garrettsville, OH 44231 Phone: 216-780-5068 |
Total Lifetime Care Medical Affiliates Inc. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Memory Ln, Suite 200, Garrettsville, OH 44231 Phone: 330-527-4852 Fax: 330-527-4866 |
News Archive
Budget negotiations: Administration gives momentum to health care cuts
Obama administration officials have advanced a significant amount of cuts from Medicare and Medicaid in the debt ceiling talks — saying the money could come from hospitals and other facilities without directly imposing new costs on beneficiaries or making radical changes to the Medicare program.
FDA approves Medtronic's new Revo MRI pacemaker
Medtronic, today announced that the U.S. Food and Drug Administration approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.
Narrative exposure therapy is effective for traumatized survivors
A group of German investigators performed a controlled study on psychological help for Rwanda orphans of war. Twenty-six orphans (originally 27) who presented with posttraumatic stress disorder (PTSD) at first assessment continued to meet a PTSD DSM-IV diagnosis 6 months after their initial assessment.
Genentech announces topline results from Phase III trial of Avastin
Genentech, Inc., a wholly owned member of the Roche Group, announced today the topline results of a Phase III trial led by the U.S. Cancer and Leukemia Group B (CALGB) and sponsored by the National Cancer Institute investigating the use of Avastin® (bevacizumab) in combination with docetaxel chemotherapy and prednisone in men with late stage prostate cancer (hormone-refractory / HRPC).
Potential blood test for chronic sinusitis identified
A protein profile has been identified in the blood of chronic sinusitis sufferers that may enable physicians to objectively diagnosis and treat the disease, researchers say.
› Verified 1 days ago